This month several new drugs were (re)introduced on the Canadian market:

• ARGATROBAN – is an anticoagulant that is a small molecule direct thrombin inhibitor.
• WINREVAIR (sotatercept) – is a medication used for the treatment of pulmonary arterial hypertension.
• DAYBUE (trofinetide) – is a medication used for the treatment of Rett syndrome.

Several drugs changed their therapeutic class:

• TABRECTA (capmatinib) – is an anticancer medication used for the treatment of metastatic non-small cell lung cancer whose tumors have a mutation that leads to the exon 14 skipping of the MET gene, which codes for the membrane receptor HGFR.
• TEPMETKO (tepotinib) – is an anti-cancer medication used for the treatment of adults with non-small cell lung cancer (NSCLC).
• VYVGART (efgartigimod alfa) – is a medication used to treat myasthenia gravis.

And the following drug was discontinued:

• caplacizumab (Cablivi)

This month several new drugs enter the Canadian market:

• The cream Opzelura (ruxolitinib) – a medication used for the treatment of intermediate or high-risk myelofibrosis, a type of myeloproliferative neoplasm that affects the bone marrow; polycythemia vera, when there has been an inadequate response to or intolerance of hydroxyurea; and steroid-refractory acute graft-versus-host disease.
• Ixchiq – vaccine against chikungunya virus
• Ojjaara (momelotinib) – an anticancer medication used for the treatment of myelofibrosis.
• Imdelltra (tarlatamab) – an anti-cancer medication used for the treatment of extensive-stage small cell lung cancer.

Discontinued drugs:

• Telzir (fosamprenavir)

This month several new drugs were introduced on the Canadian market:

• Avapritinib (Ayvakyt) is a medication used for the treatment of advanced systemic mastocytosis and indolent systemic mastocytosis.
• Lisocabtagene maraleucel (Breyanzi) is a cell-based gene therapy used to treat B-cell lymphomas, including follicular lymphoma.
• Danicopan (Voydeya) is a medication used for the treatment of paroxysmal nocturnal hemoglobinuria.

Several drugs were discontinued:

• tecovirimat (Tpoxx)
• obiltoxaximab (Anthim)

This month several new drugs were introduced on the Canadian market:

• Xenpozyme (olipudase alfa) is a medication used for the treatment of non-central nervous system (CNS) manifestations of acid sphingomyelinase deficiency type A/B or type B.
• Beyfortus (nirsevimab) is a human recombinant monoclonal antibody with activity against respiratory syncytial virus (RSV).
• Elrexfio (elranatamab) is a medication used for the treatment of multiple myeloma.

This month a new drug was introduced on the Canadian market – Wainua (eplontersen) – a medication used for the treatment of transthyretin-mediated amyloidosis.

The original brands of Gluconorm, Cymbalta and Dalacin C are discontinued. We only have generics left – repaglinide, duloxetine, clindamycin, respectively.

This month’s update introduces several new drugs on the Canadian market:

• Myalepta (metreleptin) is a synthetic analog of the hormone leptin used to treat various forms of dyslipidemia.
• Sibboran (landiolol) is an ultra short-acting, β1-superselective intravenous adrenergic antagonist, which decreases the heart rate effectively with less negative effect on blood pressure or myocardial contractility.
• Uplizna (inebilizumab) is a medication for the treatment of neuromyelitis optica spectrum disorder (NMOSD) in adults.

We compiled a list of all active ingredients in the drugs available in Canada.

The list has a convenient navigation button at the top of the page.

If you click on any ingredient, you will see the list of all drugs containing this ingredient.

The list is available in both languages – English and French.

We compiled a list of the pharmaceutical companies present in Canada.

Near each company’s name you will see the number of drug products manufactured by this company.

The companies are listed in the alphabetical order. At the top of the page you will find convenient navigation buttons.

If you click on the company’s name you will be redirected to the page that shows the complete list of products of this company.

For example, here’s the full product list of Pfizer Canada.

Now you can quickly access certain pages on Canadian-pill-identifier.com using the following keyboard shortcuts:

• Alt + t = Identify a tablet
• Alt + c = Identify a capsule
• Alt + f = Find a Drug
• Alt + i = Search by active ingredient
• Alt + p = Search by product name
• Alt + n = Search by DIN number

On Mac OS, use the option key instead of “Alt”.

We just released a major update of Canadian-pill-identifier.com. Here are some highlights:

• The signup process is simplified and is more secure.
• All elements in the search forms are now mobile-friendly.
• We revised the limitations of the free trials. Now you can make up to 4 searches per hour in our tablet and capsule identifiers. And you can view up to 2 product descriptions.
• If you signed up for a free trial or bought a subscription, your activity on the website is now logged in your profile in the section “Activity Log”.
• We now accept credit cards with our payment provider Square. PayPal payments are no longer available. We may reintroduce them in the future.